CliffBio
small molecule

BUDESONIDE

BUDESONIDE

Loss of exclusivity—loss of exclusivity
CompanyDR REDDYS LABORATORIES SA

Drug detail

Brand nameBUDESONIDE
Active ingredientBUDESONIDE
Strength3MG
Dosage formCAPSULE, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalApril 2016
Marketing statusRX

More from DR REDDYS LABORATORIES SA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.